Login/Sign Up
₹1130.5
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Eltropag 25 mg Tablet is used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Eltropag 25 mg Tablet is also used to treat severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused by the hepatitis C virus. Severe aplastic anaemia is a condition in which the bone marrow doesn't make enough blood cells.
Eltropag 25 mg Tablet contains 'Eltrombopag', which belongs to the class of 'thrombopoietin receptor agonists'. Thrombopoietin is a glycoprotein hormone, stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet production. Eltropag 25 mg Tablet works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Eltropag 25 mg Tablet helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.
In some cases, Eltropag 25 mg Tablet can cause common side effects like nausea, diarrhea, headache, muscle pain, tiredness, loss of appetite, fever, anaemia (lack of blood cells), cough and tingling numbness. If you notice any side effects that are not manageable, please consult your doctor.
Let your doctor know if you have any allergic reactions to Eltropag 25 mg Tablet or any other medicines before starting Eltropag 25 mg Tablet. Consult the doctor if you are pregnant or planning to conceive. Eltropag 25 mg Tablet is not indicated for use in breastfeeding since it passes into the breast milk.
Eltropag 25 mg Tablet is used in the treatment of low platelet count (thrombocytopenia) in various blood-related disorders. The detailed uses of Eltropag 25 mg Tablet are as follows:
Caution
Limit alcohol intake, along with Eltropag 25 mg Tablet, to attain the maximum efficacy of Eltropag 25 mg Tablet and rule out any possibility of worsening of side effects.
Unsafe
Eltropag 25 mg Tablet is not recommended in pregnancy. It may affect and harm the developing baby. Please consult your doctor if you are pregnant or planning to conceive.
Caution
It is not known if Eltropag 25 mg Tablet is excreted into the breast milk. Please consult your doctor for more information before taking Eltropag 25 mg Tablet if you are a nursing mother.
Caution
Eltropag 25 mg Tablet may cause dizziness and tiredness affecting your ability to concentrate and drive. Hence, it is recommended not to drive or operate machinery until you are mentally alert.
Caution
Let your doctor know if you have any history of liver diseases before taking Eltropag 25 mg Tablet. Eltropag 25 mg Tablet may cause an increase in liver enzymes. Your doctor may start the treatment with a lower dose of Eltropag 25 mg Tablet.
Consult your doctor
Eltropag 25 mg Tablet should be used with caution in cases of renal impairment. It is advised to seek doctor advice before starting Eltropag 25 mg Tablet if you have any kidney problems.
Caution
Eltropag 25 mg Tablet is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.
Consult your doctor
Please inform your doctor if you have a history of heart disease before using Eltropag 25 mg Tablet. Your doctor will prescribe it only if the benefits outweigh the risks.
Safe if prescribed
Eltropag 25 mg Tablet is safe for use in elderly patients if prescribed by the physician.
Have a query?
The time required for Eltropag 25 mg Tablet to start to work: Eltropag 25 mg Tablet ideally shows its action within 2 to 6 hours after administration. The time for which the effects of Eltropag 25 mg Tablet last: The duration of action for Eltropag 25 mg Tablet is clinically unknown.
Drug-Drug Interactions: Eltropag 25 mg Tablet may interact with antacids, cholesterol-lowering drugs (statins), vitamin and mineral supplements (iron, calcium, magnesium, aluminium, selenium and zinc), anti-cancer drugs (methotrexate, topotecan), drugs for rheumatoid arthritis (ciclosporin, azathioprine), HIV/AIDS drugs (lopinavir, ritonavir), corticosteroids, and steroid hormones (danazol).
Drug-Food Interactions: Take Eltropag 25 mg Tablet at least two hours before or four hours after consuming dairy products, calcium-enriched foods, and fortified juices, as these interfere with the absorption of Eltropag 25 mg Tablet.
Drug-Disease Interactions: People with blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, and liver or kidney diseases should consult the doctor before taking Eltropag 25 mg Tablet.
Login/Sign Up
Login/Sign Up
BDR Pharmaceuticals Internationals Pvt Ltd
₹570
(₹57.0 per unit)
Cipla Ltd
₹504.5
(₹72.07 per unit)
Glenmark Pharmaceuticals Ltd
₹821
(₹117.29 per unit)
Disclaimer
Recommended for a 30-day course: 3 Strips

RX
RX